Preimplantation genetic diagnosis (PGD) is performed among couples with a higher risk of transmitting a genetic condition to their offspring. The technique is employed in in-vitro fertilization centers globally to select the euploid embryos to transfer and improve the clinical outcome of the clinical pregnancy, embryo implantation, and live birth rates. As per a research study published by MDPI, embryo aneuploidy is one of the significant reasons for IVF failure enhancing the importance of the preimplantation genetic testing for aneuploidies as a mode of selecting healthy embryos with normal chromosomes. The ability to identify the preimplantation embryos with the genetic defects prior to the initiation of the pregnancy also offers an attractive alternative to chorionic villous sampling or amniocentesis.

Precision agriculture is defined as the practices adopted to make farming accurate and precise. The techniques may include the use of artificial intelligence, a wide array of technologies such as sensors, drones, robotics, automated hardware, telematics, software, and autonomous vehicles. For instance, GPS is used to receive location data from satellites and control the farmer’s tractor based on coordinates of the field. The segment covers an in-depth analysis of the drivers, restraints, and opportunities in the precision agriculture market.

The research study constitutes an in-depth study of the global positive airway pressure (PAP) devices market, including a thorough analysis of the revenue generated from the use of PAP devices in professional healthcare as well as homecare settings. Based on product launches, approvals, and ongoing strategic collaborations as well as business expansions, the market size and potential for the forecast period 2021-2030 have been estimated. The scope of this report is focused on a country-wise analysis of the global PAP devices market. The market has been segmented based on region into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

The research study constitutes an in-depth study of the global positive airway pressure (PAP) devices market, including a thorough analysis of the revenue generated from the use of PAP devices in professional healthcare as well as homecare settings. Based on product launches, approvals, and ongoing strategic collaborations as well as business expansions, the market size and potential for the forecast period 2021-2030 have been estimated. The scope of this report is focused on a country-wise analysis of the global PAP devices market. The market has been segmented based on region into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

Over the last few years, the global pharmaceutical industry has undergone significant changes. In recent years, the cost of drugs has been increasing rapidly, a majority of which is contributed by funds allocated to research and development. According to a report published by Congressional Budget Office (CBO) in April 2021, titled, ‘Research and Development in the Pharmaceutical Industry,’ the U.S. pharmaceutical industry’s R&D expenditure in 2019 was nearly $83 billion, spanning a range of activities such as drug discovery, conducting clinical tests, and drug innovation, among others. Additionally, the report also states that the budget share allocated by pharmaceutical companies toward research and development has also increased. The following table shows a rough estimate of the annual R&D expenditure of pharmaceutical companies.

Over the last few years, the global pharmaceutical industry has undergone significant changes. In recent years, the cost of drugs has been increasing rapidly, a majority of which is contributed by funds allocated to research and development. According to a report published by Congressional Budget Office (CBO) in April 2021, titled, ‘Research and Development in the Pharmaceutical Industry,’ the U.S. pharmaceutical industry’s R&D expenditure in 2019 was nearly $83 billion, spanning a range of activities such as drug discovery, conducting clinical tests, and drug innovation, among others. Additionally, the report also states that the budget share allocated by pharmaceutical companies toward research and development has also increased. The following table shows a rough estimate of the annual R&D expenditure of pharmaceutical companies.

Biomanufacturing is the process of production of commercially important biomolecules by utilizing biological systems for use in medicines, food and beverage processing, and industrial applications. Natural sources such as blood, cultures of microbes, animal cells, or plant cells are often employed to carry out biomanufacturing. Cells used in the production process can also be derived using genetic engineering techniques. Biomanufacturing refers to the method of production of biological products from living cells that are commercially important for use in medicines, food and beverage processing, and industrial applications. It is a form of biotechnology that encompasses the use of biomaterials harvested from natural sources such as microbes, blood, animal cells, or plant cells. These cells or ingredients used in the production are either naturally occurring or are synthesized through genetic engineering. In the field of medicine, several biopharmaceutical products such as vaccines, cytokines, amino acids, growth factors, antibodies, and fusion proteins are all manufactured through bioprocessing and are hence called biomanufactured products. The terms “bioprocessing” and “biomanufacturing” are often used interchangeably, the former representing the technologies and system processes, whereas the latter involves implementing bioprocessing practices to produce commercially important biomaterials and biomolecules for specific applications. One key feature distinguishing a biomanufactured product such as monoclonal antibodies from small molecule drugs such as aspirin is their production process. Biomanufacturing is a highly complex, multi-step procedure requiring much more time and expense than that needed for small molecules.

Molecular diagnostics encompasses a rapidly evolving range of assays and systems that facilitate pathogen detection, viral load estimation, antibiotic and antiviral therapy selection, diagnosis of cancer, and other diseases, by the detection and analysis of proteins and nucleic acid sequences. Molecular diagnostics also offer prognostic assessments for a wide range of diseases, as well as assistance with treatment selection and monitoring of drug treatment efficacy. Molecular diagnostics has evolved to be an integrative aspect of healthcare routines by providing most laboratory tests in infectious disease and genetics, and a continuously increasing number of tests in oncology. The massively parallel methods that have now transcended molecular diagnostics allow sequencing of entire genomes at very low costs. The sequenced databases within and between species provide the information necessary for the development of sensitive and specific diagnostic assays. The effect of extensive sequencing procedures has led to most microorganisms today being classified on the basis of sequence rather than phenotype. A presumptive diagnosis is made if a microbial sequence is present where it should not be.

Molecular diagnostics encompasses a rapidly evolving range of assays and systems that facilitate pathogen detection, viral load estimation, antibiotic and antiviral therapy selection, diagnosis of cancer, and other diseases, by the detection and analysis of proteins and nucleic acid sequences. Molecular diagnostics also offer prognostic assessments for a wide range of diseases, as well as assistance with treatment selection and monitoring of drug treatment efficacy. Molecular diagnostics has evolved to be an integrative aspect of healthcare routines by providing most laboratory tests in infectious disease and genetics, and a continuously increasing number of tests in oncology. The massively parallel methods that have now transcended molecular diagnostics allow sequencing of entire genomes at very low costs. The sequenced databases within and between species provide the information necessary for the development of sensitive and specific diagnostic assays. The effect of extensive sequencing procedures has led to most microorganisms today being classified on the basis of sequence rather than phenotype. A presumptive diagnosis is made if a microbial sequence is present where it should not be.

Europe is a highly lucrative market. The demand has been fueled by spectacular strides in the food services industry. Food manufacturers have been early adopters of innovative composite materials to meet their end-use functional characteristics. Further, the region has a marked presence of some of the globally prominent flexible manufacturers. North America and Asia Pacific are expected to offer incremental opportunities to players in the global metallized flexible packaging market. Other key reginal markets are expected to be South America and the Middle East and Africa.